HomeNDC LookupDrug shortages › Vancomycin Hydrochloride Injection

Vancomycin Hydrochloride Injection shortage

Vancomycin Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 22, 2026.

To Be Discontinued ⚠ Supply risk: High Anti-Infective 1 product 312 days First posted Nov 14, 2025 Updated Nov 14, 2025
Here’s the bottom line

Pfizer (Hospira) is permanently stopping production of the NovaPlus vancomycin hydrochloride 10 g injection vial. Other strengths of vancomycin hydrochloride injection are still listed as available from Hikma and Hospira.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
1
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/1
Affected strengths supplied
312
Days in shortage
339
Medicaid Rx (2025)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Sep 22, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Vancomycin Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
1 NDCs
To be discontinued 1
Affected strengths still supplied
Among manufacturers reporting this shortage
0/1 strengths
No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Vancomycin Hydrochloride Injection from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Hikma Pharmaceuticals USA Inc. Hospira, Inc.
Plus 16 alternative dosage forms of Vancomycin Hydrochloride.
See all other options & details →
Shortage timeline
  1. Nov 14, 2025
    Currently in shortage
    1 of 1 product affected.
  2. Nov 14, 2025
    First reported to the FDA
    1 product first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 1 NDC click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01) NDC 00409-5017-01 Discontinuation of the manufacture of the drug

These rows are manufacturer reports to the FDA for Vancomycin Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Vancomycin Hydrochloride Injection? options further down this page.

Why is Vancomycin Hydrochloride Injection in shortage?

Hospira (a Pfizer company) has reported to the FDA that they are permanently stopping the manufacture of one specific version of vancomycin hydrochloride injection — the 10 g vial sold under the NovaPlus label (NDC 0409-5017-01). That's why this particular product appears on the shortage list.

No specific reason was shared publicly for why Hospira made this decision — the FDA filing simply states it's a discontinuation of manufacturing for this product. It's worth knowing that this applies only to this one specific package and size from Hospira/Pfizer. It does not necessarily mean vancomycin injection as a whole is going away, as other manufacturers and presentations may not be affected by this decision.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Vancomycin Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Vancomycin Hydrochloride Injection?

Vancomycin Hydrochloride Injection is currently on the FDA shortage list, and I want to walk you through what that means for you.

The specific product affected is the 10 g Vial (NovaPlus) made by Hospira, Inc., a Pfizer Company. This strength has no available source reported right now, and the maker has listed it as being discontinued. In practice, that means this particular supply problem may be permanent rather than a short-term gap. No other strengths are covered by this specific record.

Because this is a discontinuation, the most important next step is a conversation with your prescriber or pharmacist. Here is how I would approach it:

  • Do not stop, skip, or change how you use this medicine on your own.
  • Ask your pharmacy to check with wholesalers, since local stock can differ from national reports.
  • The same medicine, vancomycin, is still made in several strengths by other manufacturers, including Hikma Pharmaceuticals and Hospira. Your pharmacy may be able to source one of these, though it may not be in local stock and a prescriber's guidance is needed to match your dose.
  • Ask your prescriber or pharmacist about a suitable option if this exact vial cannot be found.

Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls. This is general, national information and may not match your pharmacy's actual stock.

See “Where else can I get Vancomycin Hydrochloride Injection?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Vancomycin guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Vancomycin guide →

Where else can I get Vancomycin Hydrochloride Injection?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Vancomycin Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 1.25 g/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9152-10
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 1.5 g/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9153-10
Vancomycin Hydrochloride VANCOMYCIN 750 mg/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9355-10
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 1 g/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9357-10
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 5 g/1 Injection, Powder, For Solution · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9358-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 10 g/1 Injection, Powder, For Solution · Intravenous Hikma Pharmaceuticals USA Inc. 00143-9359-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 500 mg/5mL Injection, Powder, Lyophilized, For Solution · Intravenous Hospira, Inc. 00409-1319-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 1.5 g/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hospira, Inc. 00409-3515-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 500 mg/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hospira, Inc. 00409-4332-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 500 mg/10mL Injection, Powder, Lyophilized, For Solution · Intravenous Hospira, Inc. 00409-6509-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 750 mg/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hospira, Inc. 00409-6531-01
Vancomycin Hydrochloride VANCOMYCIN HYDROCHLORIDE 1 g/1 Injection, Powder, Lyophilized, For Solution · Intravenous Hospira, Inc. 00409-6533-21

Alternative dosage forms of Vancomycin Hydrochloride

A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:

Therapeutic equivalents & pricing 15 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Vancomycin Hydrochloride 5.13 g/gNDC 00143-9163-01 HIKMA 1 vial FDA listed
Vancomycin Hydrochloride 10.25 g/gNDC 00143-9164-01 HIKMA 1 vial FDA listed
Vancomycin Hydrochloride 10 gNDC 00143-9359-01 Hikma 1 injection AP FDA listed
Vancomycin Hydrochloride 500 mg/5mLNDC 00409-1319-01 Hospira, 1 vial AP FDA listed
Vancomycin Hydrochloride 500 mg/5mLNDC 00409-5017-01 Hospira, 1 vial AP Discontinued
Vancomycin 10 g/100mLNDC 25021-0158-99 Sagent 1 bottle AP FDA listed
Vancomycin Hydrochloride 10 gNDC 55150-0206-99 Eugia 1 vial AP FDA listed
Vancomycin Hydrochloride 10 g/100mLNDC 63323-0314-61 Fresenius 1 bottle AP FDA listed
Vancomycin Hydrochloride 100 gNDC 66288-7100-01 SAMSON 1 injection FDA listed
Vancomycin Hydrochloride 10 g/100mLNDC 67457-0342-10 Mylan 1 vial AP FDA listed
Vancomycin Hydrochloride 10 gNDC 68001-0407-75 BluePoint 1 vial AP FDA listed
Vancomycin Hydrochloride 10 g/100mLNDC 68083-0570-01 Gland 1 bottle AP FDA listed
Vancomycin Hydrochloride 10 gNDC 70436-0023-82 Slate 1 vial AP FDA listed
Vancomycin Hydrochloride 10 g/95mLNDC 71288-0026-75 Meitheal 1 vial AP FDA listed
Vancomycin Hydrochloride 500 mg/5mLNDC 72572-0207-01 Civica, 1 vial AP FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Vancomycin Hydrochloride Injection — that fall in the same broad treatment class (vancomycin antibiotics and derivatives) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 009329
GCN 41282
HICL code 004042
Ingredient (HICL) Vancomycin Hcl
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W1
Therapeutic class — intermediate (HIC2) Antibiotics
HIC3 code W1J
Therapeutic class — specific (HIC3) Vancomycin Antibiotics And Derivatives
AHFS code 08:12.28.16
AHFS class Glycopeptide Antibiotics
FDB label name VANCOMYCIN HCL 10 GM VIAL
FDB brand name Vancomycin Hcl
Legend status F — Federal legend — prescription drug or device
GPI-1416280080102130
GPI classVancomycin HCl
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other anti-infective shortages

Vancomycin Hydrochloride Injection shortage FAQs

Is Vancomycin Hydrochloride Injection in shortage?
Yes — the FDA currently lists Vancomycin Hydrochloride Injection in shortage (status: “To Be Discontinued”, first reported Nov 14, 2025). 1 of 1 product is affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01) (NDC 00409-5017-01). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Vancomycin Hydrochloride Injection be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Vancomycin Hydrochloride somewhere?
Other manufacturers (Hikma Pharmaceuticals USA Inc., Hospira, Inc.) still market it and have not reported a shortage. 16 alternative dosage forms of Vancomycin Hydrochloride are also listed. See “Where else can I get Vancomycin Hydrochloride Injection?” above — stock still varies by pharmacy.
What should I do if I take Vancomycin Hydrochloride Injection?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Vancomycin Hydrochloride Injection shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages